Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo
Published in
Diabetes, obesity & metabolism, vol. 13, no. 4, p. 326-336Publication date
2011Abstract
Keywords
- Animals
- Apoptosis
- Cells, Cultured
- Deoxyuridine/analogs & derivatives
- Diabetes Mellitus, Type 2/drug therapy/pathology
- Glucagon-Like Peptide 1/administration & dosage/analogs & derivatives/pharmacology
- Humans
- Immunohistochemistry
- Insulin-Secreting Cells/drug effects/pathology/physiology
- Male
- Peptides/administration & dosage/pharmacology
- Rats
- Rats, Zucker
- Receptors, Glucagon/administration & dosage
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
UHLES, S et al. Taspoglutide, a novel human once-weekly GLP-1 analogue, protects pancreatic β-cells in vitro and preserves islet structure and function in the Zucker diabetic fatty rat in vivo. In: Diabetes, obesity & metabolism, 2011, vol. 13, n° 4, p. 326–336. doi: 10.1111/j.1463-1326.2010.01352.x
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25288
- DOI : 10.1111/j.1463-1326.2010.01352.x
- PMID : 21205124
